Last reviewed · How we verify
NCT07371000
Early Detection of OAB and Elimination of Negative Impact on Quality of Life
NA trial testing Standardized Screening Protocol in Overactive Bladder (OAB) in 1,000 participants. Currently enrolling.
30 June 2026
Quick facts
| Lead sponsor | Institute of Health Information and Statistics of the Czech Republic |
|---|---|
| Phase | NA |
| Status | Recruiting now |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | screening |
| Enrollment | 1,000 |
| Start date | 1 September 2025 |
| Primary completion | 30 June 2026 |
| Estimated completion | 31 August 2026 |
| Sites | 20 locations across Czechia |
Drugs / interventions tested
- Standardized Screening Protocol
Conditions studied
- Overactive Bladder (OAB) — all drugs for Overactive Bladder (OAB) →
Sponsor
Institute of Health Information and Statistics of the Czech Republic
Who can join
18 and older, any sex, with Overactive Bladder (OAB). Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Overactive bladder (OAB) is one of the most common health problems in the adult population. The goal of this project is to improve the awareness of the problem and to correctly refer the targeted persons to a specialist or a doctor. This will be provided by an online screening tool, designed as web platform and mobile application, where the data will be stored in respect to GDPR. People with a positive result from the online screening tool will be offered an examination by a specialist (gynaecologist, urogynaecologist, urologist) involved in the project. The specialist will have access to the results from the online screening tool - he/she will log into the web platform with a view of the participants profile. He/she will perform the diagnosis, confirm or refute the diagnosis and complement it with any further diagnostic tests and set the standard treatment.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT07371000
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Overactive Bladder (OAB)
Currently open trials in the same condition.
- NCT07193407 — INOPASE - Performance and Safety Study of a Personalised SNM System · NA · recruiting
- NCT07209397 — Detrusor Nerve Radiofrequency Ablation for Overactive Bladder in Women · NA · recruiting
- NCT07195656 — Evaluation of a Non-Implanted Electrical Stimulation Device for Overactive Bladder (OAB) · NA · recruiting
- NCT07025044 — Assessing the Genitourinary Microbiome of Women With Overactive Bladder Undergoing Onabotulinum Toxin Type A Intradetrus · recruiting
- NCT07025642 — Comparing Treatments for Overactive Bladder in Taiwan: A Study of Outcomes · NA · recruiting
Other Institute of Health Information and Statistics of the Czech Republic trials
Trials by the same sponsor.
- NCT07015203 — The Combined First Trimester Screening · recruiting
- NCT06865326 — Early Detection of CTEPH in Patients After APE · recruiting
- NCT07057453 — National Childhood Obesity Prevention Programme BE FIT 24 · NA · recruiting
- NCT06499623 — Early Detection of Malnutrition in Oncology Patients and Elderly Patients · recruiting
- NCT06431945 — Early Detection of HCV in Injection Drug Users · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07371000 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Institute of Health Information and Statistics of the Czech Republic
- Last refreshed: 27 January 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07371000.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing